Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6289)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2019 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu SS, Xu HX, Wang WQ, Li S, Li H, Li TJ, Zhang WH, Liu L, Yu XJ. Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor. World J Gastroenterol 2019; 25(41): 6248-6257 [PMID: 31749595 DOI: 10.3748/wjg.v25.i41.6248] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i41/6248.htm |
| Number | Citing Articles |
| 1 |
Daniel Cacic, Tor Hervig, Håkon Reikvam. Platelets for advanced drug delivery in cancer. Expert Opinion on Drug Delivery 2023; 20(5): 673 doi: 10.1080/17425247.2023.2217378
|
| 2 |
Vikas B. Gubbala, Nidhi Jytosana, Vincent Q. Trinh, H. Carlo Maurer, Razia F. Naeem, Nikki K. Lytle, Zhibo Ma, Steven Zhao, Wei Lin, Haiyong Han, Yu Shi, Tony Hunter, Pankaj K. Singh, Kenneth P. Olive, Marcus C.B. Tan, Susan M. Kaech, Geoffrey M. Wahl, Kathleen E. DelGiorno. Eicosanoids in the Pancreatic Tumor Microenvironment—A Multicellular, Multifaceted Progression. Gastro Hep Advances 2022; 1(4): 682 doi: 10.1016/j.gastha.2022.02.007
|
| 3 |
Shuaishuai Xu, Chanqi Ye, Ruyin Chen, Qiong Li, Jian Ruan. The Landscape and Clinical Application of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers 2022; 14(12): 2911 doi: 10.3390/cancers14122911
|
| 4 |
Yanjun Zhou, Jonas S. Heitmann, Kim L. Clar, Korbinian N. Kropp, Martina Hinterleitner, Tobias Engler, André Koch, Andreas D. Hartkopf, Lars Zender, Helmut R. Salih, Stefanie Maurer, Clemens Hinterleitner. Platelet-expressed immune checkpoint regulator GITRL in breast cancer. Cancer Immunology, Immunotherapy 2021; 70(9): 2483 doi: 10.1007/s00262-021-02866-y
|
| 5 |
Reut Halperin, Genya Ahron-Hananel, Muhamad Badarna, Dahlia Greidinger, Inbal Uri, Ruth Percik, Amit Tirosh. Plasma Hemoglobin and Red Blood Cell Mass Levels as Dynamic Prognostic Markers for Progression and Survival in Pancreatic Neuroendocrine Tumors. Hormone and Metabolic Research 2021; 53(12): 810 doi: 10.1055/a-1672-4653
|
| 6 |
Mauro Cives, Eleonora Pellè, Maria Rinzivillo, Daniela Prosperi, Marco Tucci, Franco Silvestris, Francesco Panzuto. Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice. Neuroendocrinology 2021; 111(3): 207 doi: 10.1159/000508633
|
| 7 |
Yanghong Ni, Xiaoting Zhou, Jia Yang, Houhui Shi, Hongyi Li, Xia Zhao, Xuelei Ma. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.637675
|
| 8 |
Swayamjeet Satapathy, Anish Bhattacharya, Ashwani Sood, Rakesh Kapoor, Rajesh Gupta, Apurva Sood, Prashant Sharma, Divya Khosla, Bhagwant Rai Mittal. Hematological Markers as Predictors of Treatment Outcomes with Lutetium 177 (177Lu)-DOTATATE in Patients with Advanced Neuroendocrine Tumors. Cancer Biotherapy and Radiopharmaceuticals 2022; 37(1): 23 doi: 10.1089/cbr.2021.0053
|
| 9 |
Mengfei Fu, Li Yu, Liu Yang, Yang Chen, Xiao Chen, Qinyu Hu, Hui Sun. Predictive value of the preoperative prognostic nutritional index for postoperative progression in patients with pancreatic neuroendocrine neoplasms. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.945833
|
| 10 |
Martina Hinterleitner, Bence Sipos, Verena Wagner, Julia M. Grottenthaler, Ulrich M. Lauer, Lars Zender, Clemens Hinterleitner. Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies. Cancers 2021; 13(10): 2286 doi: 10.3390/cancers13102286
|
| 11 |
Ling‐Jun Cui, Fu‐Huan Yu, Zi‐Xuan Cheng, Fei Su, Ying‐Ying Chen, Huang‐Ying Tan. Prognostic value of inflammation‐related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta‐analysis. Journal of Neuroendocrinology 2024; 36(4) doi: 10.1111/jne.13381
|
| 12 |
Shuai-Shuai Xu, Hao Li, Tian-Jiao Li, Shuo Li, Huan-Yu Xia, Jiang Long, Chun-Tao Wu, Wen-Quan Wang, Wu-Hu Zhang, He-Li Gao, Xuan Han, Long-Yun Ye, Xuan Lin, Hua-Xiang Xu, Xian-Jun Yu, Liang Liu. Neutrophil Extracellular Traps and Macrophage Extracellular Traps Predict Postoperative Recurrence in Resectable Nonfunctional Pancreatic Neuroendocrine Tumors. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.577517
|
| 13 |
Paweł Komarnicki, Jan Musiałkiewicz, Alicja Stańska, Adam Maciejewski, Paweł Gut, George Mastorakos, Marek Ruchała. Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future. Journal of Clinical Medicine 2022; 11(19): 5542 doi: 10.3390/jcm11195542
|
| 14 |
Gitta Boons, Timon Vandamme, Joe Ibrahim, Geert Roeyen, Ann Driessen, Dieter Peeters, Ben Lawrence, Cristin Print, Marc Peeters, Guy Van Camp, Ken Op de Beeck. PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis. Cancers 2020; 12(6): 1461 doi: 10.3390/cancers12061461
|
| 15 |
Xin Chen, Jing Li, Xunlei Zhang, Yushan Liu, Jindong Wu, Yangcheng Li, Xiaopeng Cui, Xiaohui Jiang. Prognostic and clinicopathological significance of pretreatment mean platelet volume in cancer: a meta-analysis. BMJ Open 2020; 10(10): e037614 doi: 10.1136/bmjopen-2020-037614
|
| 16 |
Byeong-Oh Hwang, Se-Young Park, Eunae Sandra Cho, Xianglan Zhang, Sun Kyoung Lee, Hyung-Joon Ahn, Kyung-Soo Chun, Won-Yoon Chung, Na-Young Song. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.807600
|
| 17 |
Yuanliang Li, Guohui Fan, Fuhuan Yu, Chao Tian, Huangying Tan. Meta-Analysis of Prognostic Factors for Recurrence of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors. Neuroendocrinology 2021; 111(12): 1231 doi: 10.1159/000514047
|
| 18 |
Lilan Chen, Chunyan Zhu, Fan Pan, Ying Chen, Lei Xiong, Yan Li, Xiaoyuan Chu, Guichun Huang. Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1121401
|
| 19 |
Guanhua Chen, Li Liu, Chunlu Tan, Qingquan Tan, Yonghua Chen, Xiangrong An, Xubao Liu, Xing Wang. Prognostic significance of systemic immune‐inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection. Cancer Medicine 2024; 13(7) doi: 10.1002/cam4.7114
|
| 20 |
Rachel Broadbent, Roseanna Wheatley, Sabrina Stajer, Timothy Jacobs, Angela Lamarca, Richard A Hubner, Juan W Valle, Eitan Amir, Mairéad G McNamara. Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis. Cancer Treatment Reviews 2021; 101: 102299 doi: 10.1016/j.ctrv.2021.102299
|
| 21 |
Hans-Åke Fabricius, Sarah Starzonek, Tobias Lange. The Role of Platelet Cell Surface P-Selectin for the Direct Platelet-Tumor Cell Contact During Metastasis Formation in Human Tumors. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.642761
|
| 22 |
Ophélie Le Chapelain, Benoît Ho-Tin-Noé. Intratumoral Platelets: Harmful or Incidental Bystanders of the Tumor Microenvironment?. Cancers 2022; 14(9): 2192 doi: 10.3390/cancers14092192
|
| 23 |
Sara Bravaccini, Elisa Boldrin, Giorgia Gurioli, Gianluca Tedaldi, Maria Assunta Piano, Matteo Canale, Matteo Curtarello, Paola Ulivi, Pierluigi Pilati. The use of platelets as a clinical tool in oncology: opportunities and challenges. Cancer Letters 2024; 607: 217044 doi: 10.1016/j.canlet.2024.217044
|